RI

REGENXBIO Inc.

Organization

Heard in 6 episodes across 5 shows since Jun 2026

REGENXBIO Inc. is a clinical-stage biotechnology company focused on the development, commercialization, and licensing of recombinant adeno-associated virus (rAAV) gene therapy. The company utilizes its proprietary NAV Technology Platform to design and deliver curative gene therapies for diseases with significant unmet medical needs.

Episodes

6
across 5 shows

First heard

Jun 2026

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20261
Jul 20260
Aug 20261
Sep 20261
Oct 20263

Episodes

6 episodes featuring REGENXBIO Inc., newest first

REGENXBIO Inc. · PodLume